Prostate-specific antigen: An unfamiliar protein in the human salivary glands.
Isola M, Maxia C, Murtas D, Ekström J, Isola R, Loy F., Free PMC Article

Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer.
Spyratou V, Freyhult E, Bergh A, Thellenberg-Karlsson C, Wikström P, Welén K, Josefsson A.

RNA-binding protein 14 promotes phase separation to sustain prostate specific antigen expression under androgen deprivation in human prostate cancer.
Tsuji K, Kawata H, Kamiakito T, Nakaya T, Tanaka A.

Association of Kallikrein Related Peptidase 3 (KLK3) gene with dermatophytosis in the UK biobank cohort.
Lehrer S, Rheinstein PH., Free PMC Article

The effect of encomir-93 mimic transfection on the expression of miR-93 and PSA and androgen receptor in prostate cancer LNcap cell line.
Mokhtari H, Ebrahimi A, Nejati M, Barartabar Z, Damchi M, Khonakdar-Tarsi A, Zahedi M.

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death.
Tilki D, Chen MH, Wu J, Huland H, Graefen M, Mohamad O, Cowan JE, Feng FY, Carroll PR, D'Amico AV., Free PMC Article

[Immuno-analytical characteristics of PSA and derived biomarkers (total PSA, free PSA, p2PSA)].
Desbène C, Boissan M, Loric S, Lamy PJ, Piéroni L.

Diagnostic Efficacy of PSMA and PSCA mRNAs Combined to PSA in Prostate Cancer Patients.
Mahmoud MM, Abdel Hamid FF, Abdelgawad I, Ismail A, Malash I, Ibrahim DM., Free PMC Article

KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression.
Xu J, Shi Z, Wei J, Na R, Resurreccion WK, Wang CH, Sample C, Han M, Zheng SL, Cooney KA, Helfand BT, Isaacs WB.

Correlation analysis between CD133, Klk3 and grhl2 expression and tumor characteristics in prostate cancer.
Wu J, Guo S, Wang L, Liao Z.

Age-Adjusted Reference Values for Prostate Specific Antigen - A Systematic Review and Meta-Analysis.
Matti B, Xia W, van der Werf B, Zargar-Shoshtari K.

Exome sequencing identifies RASSF1 and KLK3 germline variants in an Iranian multiple-case breast cancer family.
Radmanesh H, Liu D, Geffers R, Shandiz FH, Sadr-Nabavi A, Hillemanns P, Park-Simon TW, Dörk T.

Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatment.
Boerrigter E, Benoist GE, van Oort IM, Verhaegh GW, van Hooij O, Groen L, Smit F, Oving IM, de Mol P, Smilde TJ, Somford DM, Mehra N, Schalken JA, van Erp NP., Free PMC Article

The Role of PSA Density among PI-RADS v2.1 Categories to Avoid an Unnecessary Transition Zone Biopsy in Patients with PSA 4-20 ng/mL.
Wang ZB, Wei CG, Zhang YY, Pan P, Dai GC, Tu J, Shen JK., Free PMC Article

KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy.
Lunger L, Retz M, Bandur M, Souchay M, Vitzthum E, Jäger M, Weirich G, Schuster T, Autenrieth M, Kübler H, Maurer T, Thalgott M, Herkommer K, Koll F, Gschwend JE, Nawroth R, Heck MM., Free PMC Article

KLK3 in the Regulation of Angiogenesis-Tumorigenic or Not?
Koistinen H, Künnapuu J, Jeltsch M., Free PMC Article

Hidden clues in prostate cancer - Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification.
Toivanen R, Porter LH, Li Z, Clouston D, Risbridger GP, Taylor RA.

Association of decreased sperm motility and increased seminal plasma IGF-I, IGF-II, IGFBP-2, and PSA levels in infertile men.
Fu L, Yuen KCJ, Tint AN, Hoffman AR, Bongso AT, Lee KO.

The role of prostate-specific antigen and multiparametric magnetic resonance imaging in the diagnosis of granulomatous prostatitis induced by intravesical Bacillus Calmette-Guérin vaccine therapy in patients with nonmuscle invasive bladder cancer.
Wang Z, Han C, Xu Y, Yu X, Kang W, Xiang Y, Yuan Y, Li L, Wang M.

KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.
Lin HY, Huang PY, Cheng CH, Tung HY, Fang Z, Berglund AE, Chen A, French-Kwawu J, Harris D, Pow-Sang J, Yamoah K, Cleveland JL, Awasthi S, Rounbehler RJ, Gerke T, Dhillon J, Eeles R, Kote-Jarai Z, Muir K, UKGPCS collaborators, Schleutker J, Pashayan N, APCB (Australian Prostate Cancer BioResource), Neal DE, Nielsen SF, Nordestgaard BG, Gronberg H, Wiklund F, Giles GG, Haiman CA, Travis RC, Stanford JL, Kibel AS, Cybulski C, Khaw KT, Maier C, Thibodeau SN, Teixeira MR, Cannon-Albright L, Brenner H, Kaneva R, Pandha H, PRACTICAL consortium, Srinivasan S, Clements J, Batra J, Park JY., Free PMC Article

Sex-dependent expression of prostatic markers and hormone receptors in cystic tumor of the atrioventricular node: A histopathological study of three cases.
Ichimata S, Hata Y, Yajima N, Katayama Y, Nomoto K, Nishida N.

Early prediction of prostate cancer biochemical recurrence and identification of disease persistence using PSA isoforms and human kallikrein-2.
Do Carmo Silva J, Vesely S, Luksanova H, Prusa R, Babjuk M.

Could Kallikrein-Related Serine Peptidase 3 Be an Early Biomarker of Environmental Exposure in Young Women?
Raimondo S, Gentile M, Esposito G, Gentile T, Ferrara I, Crescenzo C, Palmieri M, Cuomo F, De Filippo S, Lettieri G, Piscopo M, Montano L., Free PMC Article

Estimation levels of prostate-specific antigen, interleukin-8, oxidative stress and some inflammatory markers in sera of benign prostatic hyperplasia patients who have smoking habits as a risk factor.
Al-Barzinj RMGT.

Association of KLK3, VAMP8 and MDM4 Genetic Variants within microRNA Binding Sites with Prostate Cancer: Evidence from Serbian Population.
Kotarac N, Dobrijevic Z, Matijasevic S, Savic-Pavicevic D, Brajuskovic G.